Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

Vor Biopharma Pivots to Autoimmune Disease with New CEO and $175M Financing

Vor Biopharma Pivots to Autoimmune Disease with New CEO and $175M Financing

Vor Biopharma, a Massachusetts-based biotech company, has announced a significant shift in its strategic focus, moving away from oncology to target autoimmune diseases. This transformation comes with new leadership and a substantial financial boost, marking a pivotal moment for the company.

NoahAI News6/27/2025
ForSight Robotics Secures $125M for Revolutionary Eye Surgery Platform

ForSight Robotics Secures $125M for Revolutionary Eye Surgery Platform

ForSight Robotics, an Israel-based medical technology company, has raised $125 million in a Series B funding round to advance its groundbreaking robotic eye surgery platform. The investment will support the company's preparations for first-in-human clinical trials of robotic cataract surgery, slated to begin later this year.

NoahAI News6/27/2025
Lilly's Acquisition of Verve Therapeutics: A Turbulent Journey Amid Regulatory Upheaval

Lilly's Acquisition of Verve Therapeutics: A Turbulent Journey Amid Regulatory Upheaval

In a landmark deal that underscores the volatile nature of the gene editing sector, Eli Lilly has agreed to acquire Verve Therapeutics for $1.3 billion. The merger, announced on June 17, 2025, comes after months of intense negotiations and market turbulence, revealing the complex interplay of regulatory changes, political decisions, and industry dynamics that shape the pharmaceutical landscape.

NoahAI News6/27/2025
Minovia Therapeutics Goes Public with $180M SPAC Deal, Advancing Mitochondrial Therapy

Minovia Therapeutics Goes Public with $180M SPAC Deal, Advancing Mitochondrial Therapy

Minovia Therapeutics, an Israeli biotech company specializing in mitochondrial augmentation technology, has announced its plans to go public through a special purpose acquisition company (SPAC) deal valued at $180 million. The transaction, expected to close in the fourth quarter of this year, will see Minovia combine with Launch One Acquisition Corp. to form a new entity called Mito US One.

NoahAI News6/27/2025
Best Buy Divests Current Health as Home Care Sector Faces Challenges

Best Buy Divests Current Health as Home Care Sector Faces Challenges

Best Buy has sold its home care firm Current Health back to co-founder Christopher McGhee, marking a significant shift in the electronics retailer's healthcare strategy. The divestiture comes amid broader challenges in the home care and retail healthcare sectors, with several major players reassessing their investments.

NoahAI News6/27/2025
Novartis Expands Cardiovascular Pipeline with $750M+ ProFound Therapeutics Deal

Novartis Expands Cardiovascular Pipeline with $750M+ ProFound Therapeutics Deal

Novartis has entered into a significant partnership with Flagship Pioneering's ProFound Therapeutics, marking another major investment in the cardiovascular disease space. The four-year collaboration, announced on Thursday, aims to discover and develop novel protein therapies for cardiovascular conditions using ProFound's proprietary technology.

NoahAI News6/27/2025
Prospect Medical Systems Faces Layoffs Amid Bankruptcy and Asset Sales

Prospect Medical Systems Faces Layoffs Amid Bankruptcy and Asset Sales

Prospect Medical Systems, a management services organization owned by Prospect Medical Holdings, is set to lay off 125 administrative workers in California effective July 1, according to recent filings with state regulators. This development comes as part of a larger restructuring effort following Prospect Medical Holdings' Chapter 11 bankruptcy filing in January.

NoahAI News6/27/2025
Acadia Pharmaceuticals Unveils Ambitious Pipeline and Sales Forecasts

Acadia Pharmaceuticals Unveils Ambitious Pipeline and Sales Forecasts

Acadia Pharmaceuticals, a prominent brain drug developer, has announced ambitious sales projections for its marketed products and pipeline candidates during its recent research and development event. The company's bullish outlook has sparked renewed interest among investors and analysts, potentially signaling a turnaround for the pharmaceutical firm.

NoahAI News6/27/2025
Incyte Announces CEO Transition, Raising M&A Speculation

Incyte Announces CEO Transition, Raising M&A Speculation

Incyte Corporation, a prominent player in the pharmaceutical industry, has announced a significant leadership change with the appointment of Bill Meury as its new CEO, effective immediately. This transition marks the end of Hervé Hoppenot's 11-year tenure at the helm of the company, during which Incyte experienced substantial growth and diversification.

NoahAI News6/27/2025
FDA Expands Use of GE HealthCare's Vizamyl in Alzheimer's Diagnostics

FDA Expands Use of GE HealthCare's Vizamyl in Alzheimer's Diagnostics

The U.S. Food and Drug Administration (FDA) has broadened the applications of GE HealthCare's Vizamyl (flutemetamol F-18) imaging agent, marking a significant advancement in Alzheimer's disease diagnostics. This expansion allows for more objective assessments and the ability to monitor treatment efficacy, potentially revolutionizing patient care in the field of neurodegenerative disorders.

NoahAI News6/27/2025
CDC Advisory Panel Recommends Merck's New RSV Antibody Amid Controversy

CDC Advisory Panel Recommends Merck's New RSV Antibody Amid Controversy

The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has endorsed Merck's newly approved respiratory syncytial virus (RSV) antibody, Enflonsia, for use in infants. The recommendation, however, comes amid significant changes to the panel's composition and ongoing debates about vaccine policy.

NoahAI News6/27/2025
Walgreens Reports Q3 Loss as Sycamore Acquisition Looms

Walgreens Reports Q3 Loss as Sycamore Acquisition Looms

Walgreens Boots Alliance, one of the largest pharmacy retailers in the United States, reported a significant net loss in its third quarter as the company prepares for its upcoming acquisition by private equity firm Sycamore Partners. The drugstore chain's financial results reflect ongoing challenges in its retail segment, while its pharmacy and international businesses show resilience.

NoahAI News6/27/2025
«1...345...67»